The latest update is out from Exagen (XGN).
Exagen Inc. has announced the appointment of Jeffrey Black as their new Chief Financial Officer, effective September 1, 2024. Black, with a strong background in financial roles across various medical technology and biotech companies, will be receiving a competitive compensation package, including a base salary, signing bonus, performance bonus, and an equity award. Meanwhile, John Aballi steps in as the Interim CFO, following Kamal Adawi’s departure. No family ties or transactions requiring disclosure have been reported between the new appointees and the company’s executives. The recent executive changes have been publicized through a press release by the company.
Learn more about XGN stock on TipRanks’ Stock Analysis page.
